GlassScriptPhysician profile
Tricia L Cattani
NPI 1912243692
$714.80
in general payments reported to CMS, 2019-2025
16 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.38 · 2022: $14.54 · 2024: $363 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.88 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $151.20 | 2025 | Gamunex-C |
| Janssen Biotech, INC. | $132.55 | 2024 | Tremfya |
| Tg Therapeutics, INC. | $125.00 | 2025 | |
| Incyte Corporation | $55.49 | 2024 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $36.04 | 2024 | Dupixent, Libtayo |
| Argenx US, INC. | $31.66 | 2024 | Vyvgart, Vyvgart Hytrulo |
| Ucb, INC. | $25.61 | 2025 | Rystiggo |
| Glaxosmithkline, LLC. | $21.09 | 2025 | Nucala |
| Alexion Pharmaceuticals, INC. | $19.92 | 2024 | Ultomiris |
| Genentech USA, INC. | $18.98 | 2024 | Ocrevus Zunovo, Ocrevus |
| Lilly USA, LLC | $18.48 | 2024 | Taltz, Olumiant |
| Leo Pharma INC. | $17.71 | 2024 | Adbry |
| Verrica Pharmaceuticals INC. | $16.08 | 2024 | Ycanth |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.07 | 2024 | Cabtreo |
| Emd Serono, INC. | $14.54 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Cattani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.